SpringerLink
Log in

Hodgkin’s lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Chim CS, Lie AK, Chan EY, Leung YY, Cheung SC, Chan SY, Liang R, Kwong YL (2010) A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma. Ann Hematol 89(10):1019–1027

    Article  PubMed  CAS  Google Scholar 

  2. Chim CS, Lie AK, Chan EY, Liu HS, Lau CW, Yip SF, Sim J, Wan TS, Ma ES, Liang R, Tse E, Kwong YL (2012) Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD. J Hematol Oncol 5(1):28

    Article  PubMed  CAS  Google Scholar 

  3. Attal M, Lauwers-Cances V, Marit G, Caillot D, Moreau P, Facon T, Stoppa AM, Hulin C, Benboubker L, Garderet L, Decaux O, Leyvraz S, Vekemans MC, Voillat L, Michallet M, Pegourie B, Dumontet C, Roussel M, Leleu X, Mathiot C, Payen C, Avet-Loiseau H, Harousseau JL, IFM Investigators (2012) Lenalidomide maintenance after stem-cell transplantation for multiple myeloma. N Engl J Med 366(19):1782–1791

    Article  PubMed  CAS  Google Scholar 

  4. McCarthy PL, Owzar K, Hofmeister CC, Hurd DD, Hassoun H, Richardson PG, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, Isola L, Maziarz RT, Gabriel DA, Bashey A, Landau H, Martin T, Qazilbash MH, Levitan D, McClune B, Schlossman R, Hars V, Postiglione J, Jiang C, Bennett E, Barry S, Bressler L, Kelly M, Seiler M, Rosenbaum C, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Anderson KC, Linker C (2012) Lenalidomide after stem-cell transplantation for multiple myeloma. N Engl J Med 366(19):1770–1781

    Article  PubMed  CAS  Google Scholar 

  5. Hasskarl J, Ihorst G, De Pasquale D, Schröttner P, Zerweck A, Wäsch R, Engelhardt M (2011) Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 52(2):247–259

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, SAR, China

    Chor Sang Chim

  2. Department of Nuclear Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong, SAR, China

    Pak Tat Choi

  3. Department of Pathology, Pok Oi Hospital, Yuen Long, Hong Kong, SAR, China

    Wai Ki Lee

Authors
  1. Chor Sang Chim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pak Tat Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wai Ki Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chor Sang Chim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chim, C.S., Choi, P.T. & Lee, W.K. Hodgkin’s lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide. Ann Hematol 92, 855–857 (2013). https://doi.org/10.1007/s00277-012-1639-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1639-3

Keywords

Search

Navigation